Showing results (211-220 of 219) with videos related to
Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 219 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 29, 1999
Isolated renal Aspergillus abscess in an AIDS patient with a normal CD4+ cell count on highly active antiretroviral therapyD Rey, E de Mautort, C Saussine, et al.Langmuir : the ACS Journal of Surfaces and Colloids|July 27, 2017
Contact Angle and Adhesion Dynamics and Hysteresis on Molecularly Smooth Chemically Homogeneous SurfacesSzu-Ying Chen, Yair Kaufman, Alex M Schrader, et al.Langmuir : the ACS Journal of Surfaces and Colloids|June 15, 2018
Probing Additive Loading in the Lamellar Phase of a Nonionic Surfactant: Gibbs Ensemble Monte Carlo Simulations Using the SDK Force FieldMona S Minkara, Rebecca K Lindsey, Celeste O. Noether, et al.Proceedings of the National Academy of Sciences of the United States of America|July 21, 2018
Rates of cavity filling by liquidsDongjin Seo, Alex M Schrader, Szu-Ying Chen, et al.Langmuir : the ACS Journal of Surfaces and Colloids|August 6, 2019
Automated Measurement of Spatially Resolved Hair-Hair Single Fiber AdhesionThomas R Cristiani, Nicholas A Cadirov, Zhanping Zhang, et al.Journal of Neurotrauma|June 24, 2010
Clinical evaluation of a portable near-infrared device for detection of traumatic intracranial hematomasClaudia S Robertson, Eric L Zager, Raj K Narayan, et al.Cancer|March 29, 2014
Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancerRashmi K Murthy, Ankur Varma, Priyankana Mishra, et al.Investigational New Drugs|January 6, 2019
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II studyClinton Yam, Francisco J Esteva, Miral M Patel, et al.ESMO Open|September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancersE E Dumbrava, S G Call, H J Huang, et al.Pageof 22